Serum ICAM-1 concentrations following conventional dose consolidation chemotherapy for acute myeloid leukemia and after high dose chemotherapy with autologous haematopoietic stem cell rescue.

International journal of oncology

Volumn 17, Issue 3, 2000, Pages 591-595

  Wang, X ^a   Clowes, C ^a   Duarte, R ^a   Pu, Q Q ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CYTARABINE; ETOPOSIDE; IDARUBICIN; INTERCELLULAR ADHESION MOLECULE 1; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TUMOR PROTEIN;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MYELOID LEUKEMIA; NEUTROPENIA; NEUTROPHIL; SOLUBILITY;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL MARKERS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; CYTARABINE; ETOPOSIDE; FEMALE; FILGRASTIM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IDARUBICIN; INTERCELLULAR ADHESION MOLECULE-1; LEUKEMIA, MYELOID; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEUTROPENIA; NEUTROPHILS; SOLUBILITY;

MLCS; MLOWN;

EID: 0034265767     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.17.3.591     Document Type: Article

References (0)